✦ LIBER ✦

385 A first in human phase 1 study of the safety and pharmacokinetics of a novel Cdc7 inhibitor NMS-1116354, administered orally to patients with solid tumors

✍ Scribed by K. Papadopoulos; S. Crippa; A. Hanssen; A. Montagnoli; F. Fiorentini; A.W. Tolcher; M. Martignoni; A. Isacchi; B. Laffranchi; A. Patnaik

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

97 POSTER A phase I dose-escalation stud

✍ K. Papadopoulos; J. Rodon; A. Mita; P. O'Rourke; A. Patnaik; E. Rubin; A. Tolche 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

218 POSTER A phase I dose-escalation stu

✍ E. Calvo; G. Edelman; J. Baselga; E. Kwak; C. Scheffold; L. Nguyen; G.I. Shapiro 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

216 POSTER A phase I dose-escalation stu

✍ B. Markman; P.M. LoRusso; A. Patnaik; E. Heath; A.D. Laird; B. van Leeuwen; K.P. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 72 KB

A Phase 1 dose-escalation study of the s

✍ Shapiro, Geoffrey I.; McCallum, Stewart; Adams, Laurel M.; Sherman, Laurie; Well 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 260 KB

419 Pharmacokinetic (PK) assessment of b

✍ R. Abbas-Borhan; J. Boni; P. Hsyu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

A phase I study of the safety and pharma

✍ Herbert I. Hurwitz; Roger B. Cohen; J. Patrick McGovren; Samit Hirawat; William 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 308 KB